In-clinic & remote cognitive care—trusted by 4,000+ providers

Screening and caring for over 400,000 patients with our reimbursable FDA Class II and HIPAA-compliant platform since 2015



Book a demo

A complete toolset for providers.
A better journey for patients and families.

From screening to monitoring, it’s an all-in-one, fully-digital solution to accelerate intervention, empower action, and elevate the standard of care – from any device, in any location.

keyfact icon
BrainCheck Screen™
3-5 minutes | 3 domains

Accurately and efficiently check cognitive health and determine if further testing may be needed.

Learn more
keyfact icon
BrainCheck Assess™
15 minutes | 5 domains
FDA Class II Medical Device

Detect subtle signs of cognitive impairment, which may have association with dementias, including Alzheimer’s disease.

Reimbursable

Learn more
keyfact icon
BrainCheck Plan™
30 minutes

Build, document, and deliver a comprehensive care plan for patients with cognitive decline, post-diagnosis.

Reimbursable

Learn more

Earlier is better.

Cognitive impairment is extremely common – early detection is key to unlocking opportunities to preserve brain health. With prevalence on the rise, it’s time for a better way.

Why use digital tests
A young doctor with a digital tablet device is explaining the benefits of neurocognitive evaluation to a patient in her clinical practice, emphasizing patient care

Digital tools for a new era in brain health

Our next-generation digital solutions promote proactive screening, detect early signs of decline, and enable care planning, equipping providers from primary care to specialists with a complete toolset to maximize the window of intervention and take action.

Explore the toolset

Better cognitive care starts here.

7 million +

Americans are currently unaware they have mild cognitive impairment

Up to %
of these patients could go on to develop Alzheimer’s or dementia without intervention
Up to %
of these patients could go on to develop Alzheimer’s or dementia without intervention

We’re closing the gap

We’re closing the gap

Up to %
of Alzheimer’s disease and related dementias may be preventable or delayed by addressing key risk factors 

See what our customers are saying

“Before using BrainCheck, we used traditional pencil-and-paper tests and we found these difficult to use as they were very subjective. Using BrainCheck was a perfect solution to elevate our clinical insights and helps us provide better patient care.” 
Bruce Lowell, MDGeriatrician and Board-certified internist, New York Hospital Queens, North Shore Hospital Manhasset
“BrainCheck has streamlined our cognitive care process, from rapid screenings to in-depth assessments and empathetic care planning, offering a modern solution with clear benefits.”
Stacey Epps, MDExecutive Medical Director, Bon Secours Neuroscience Institute
“With BrainCheck Screen, we can accurately and efficiently check cognitive health, allowing us to easily comply with Medicare requirements to assess cognitive function during annual wellness visits. It helps us rapidly determine which patients require additional testing and enhances our patient care.” 
Eric R. Penniman, D.O.Executive Medical Director, Summit Medical Group
“We owe it to our patients to shed light on a cognitive issue that could become problematic as soon as possible, and BrainCheck can help physicians achieve this quickly and easily.”
Reuben Elovitz, MDCEO & Internal Medicine Physician, Private Health Dallas
“BrainCheck’s technology is essential for providers to meet the GUIDE Model’s required core elements. From thorough assessments to personalized care plans, BrainCheck equips healthcare professionals to address the unique needs of each patient and care partner effectively.”
Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA, FAANProfessor and Founder of Integrated Memory Care at Emory University

Latest news and insights

Ready to get started?

A new, more accessible journey towards empowered and informed brain health awaits.

Book a demo

References

  1. BrainCheck Screen Validation. (2023). Accessible via BrainCheck.com.
  2. Ye S, Sun K, Huynh D, Phi HQ, Ko B, Huang B, Hosseini Ghomi R. A Computerized Cognitive Test Battery for Detection of Dementia and Mild Cognitive Impairment: Instrument Validation Study. JMIR Aging 2022;5(2):e36825 doi: 10.2196/36825
  3. Groppell S, Soto-Ruiz KM, Flores B, Dawkins W, Smith I, Eagleman DM, Katz Y. A Rapid, Mobile Neurocognitive Screening Test to Aid in Identifying Cognitive Impairment and Dementia (BrainCheck): Cohort Study JMIR Aging 2019;2(1):e12615. https://doi.org/10.2196/12615
  4. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30. PMID: 38689398; PMCID: PMC11095490.
  5. Soeren Mattke et al, Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis, Alzheimer’s Research & Therapy (2023). DOI: 10.1186/s13195-023-01272-z
  6. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–446. https://doi.org/10.1016/S0140-6736(20)30367-6

Some feature availability determined by EHR integration.

Scroll to Top